Sebia

Sebia — FDA 510(k) Submissions

Sebia has submitted 32 FDA 510(k) premarket notifications since 1995, of which 32 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Immunoelectrophoretic, Immunoglobulins, (g, A, M), Abnormal Hemoglobin Quantitation, Assay, Glycosylated Hemoglobin, Electrophoretic, Lactate Dehydrogenase Isoenzymes, Electrophoretic, Protein Fractionation . Use the specialty filter in the sidebar to narrow results.